India's Richest People 2019 edition · Source: Hurun India
Rank#484- Wealth
- ₹1,800 Cr
- Company
- Ajanta Pharma
2018 #514
RM
Rajesh Mannalal Agrawal
Active Director Whole-Time Director DIN 00302467
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 38 historical roles
Total affiliations 42 Since Dec 2001
Shareholding value •••• Premium profile
About Rajesh Mannalal Agrawal
Data last updated:
Rajesh Mannalal Agrawal is a Whole-Time Director at Ajanta Pharma Limited (since 2013), Director at Gabs Investments Private Limited (since 2017) and Director at Rivea Foundation (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Financial Services and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹4,778 Cr; the largest is Ajanta Pharma Limited at ₹4,743 Cr (FY 2025). Earlier, Rajesh Mannalal Agrawal was a Director at Sbfc Finance Limited (2020–2025) and Partner at Alpha Alternatives Msar Llp (2023–2024) and 36 more.
Rajesh Mannalal Agrawal was among India's richest people in 2019 at #484.
DIN 00302467
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 28 Dec 2001
Oldest Company Age 46 yrs
Largest company Ajanta Pharma Limited · ₹4,743 Cr (FY 2025)
Combined revenue ₹4,778 Cr across 3 companies
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ajanta Pharma Limited L24230MH1979PLC022059 | Whole-Time Director | 30 Apr 2013 | 1979 | ₹4,743 Cr (FY 2025) | Active |
 Gabs Investments Private Limited U99999MH1995PTC084335 | Director | 01 Mar 2017 | 1995 | ₹35.46 Cr (FY 2025) | Active |
| Rivea Foundation U86100MH2024NPL432419 | Director | 20 Sep 2024 | 2024 | ₹20 Lakh (FY 2025) | Active |
| Riteaid Enterprises Llp AAL-4662 | Designated Partner | 20 Dec 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sbfc Finance Limited L67190MH2008PLC178270 | Director | 11 Nov 2020 | 2008 | ₹1,020 Cr (FY 2024) | Active |
| Alpha Alternatives Msar Llp AAW-2814 | Partner | 03 Jul 2023 | 2021 | ₹4,486 Cr (FY 2025) | Active |
| Altacura Ai Absolute Return Fund Llp AAX-3837 | Partner | 31 Aug 2023 | 2021 | ₹111 Cr (FY 2024) | Active |
 Cdc Pharma Private Limited U24230MH2005PTC154325 | Director | 29 Jun 2005 | 2005 | Converted To Llp | |
| Zillion Labs Private Limited U24230MH2005PTC154375 | Director | 30 Jun 2006 | 2005 | Converted To Llp | |
| Inspira Solar Energy Private Limited U26900MH2007PTC176812 | Director | 01 Nov 2010 | 2007 | Strike Off | |
 Inspira Living Concepts Private Limited U24230MH2005PTC154279 | Director | 28 Jun 2005 | 2005 | Strike Off | |
| Vetrium Health Private Limited U24232MH2007PTC167751 | Director | 10 Feb 2007 | 2007 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Mannalal Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kanhaiyalal Agrawal | Ajanta Pharma Limited | Cfo | |
| David Paul Rasquinha | 01172654 | Ajanta Pharma Limited | Director |
| Gaurang Chinubhai Shah | Ajanta Pharma Limited | Company Secretary | |
| Madhusudan Bhagwandas Agrawal | 00073872 | Ajanta Pharma Limited | Whole-Time Director |
| Mannalal Bhagwandas Agrawal | 00073828 | Ajanta Pharma Limited | Director |
| Medha Vinay Joshi | 00328174 | Ajanta Pharma Limited | Director |
| Rajesh Shashikant Dalal | 03504969 | Ajanta Pharma Limited | Director |
| Simi Manohar Lal Thapar | 10470498 | Ajanta Pharma Limited | Director |
| Yogesh Mannalal Agrawal | 00073673 | Ajanta Pharma Limited , Gabs Investments Private Limited | Managing Director |
| Aayush Madhusudan Agrawal | 03129764 | Gabs Investments Private Limited | Director |
| Ravi Purushottam Agrawal | 00302243 | Gabs Investments Private Limited | Director |
| Smriti Rajesh Agrawal | 00075064 | Rivea Foundation , Riteaid Enterprises Llp | Director |
Directorship timeline
Open interactive timeline →Riteaid Enterprises Llp
Ajanta Pharma Limited
Gabs Investments Private Limited
Rivea Foundation
Premium access
Shareholding and investment profile for Rajesh Mannalal Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Mannalal Agrawal
Rajesh Mannalal Agrawal currently holds 4 directorships: Ajanta Pharma Limited (Whole-Time Director, since 30 Apr 2013, revenue ₹4,743 Cr (FY 2025)); Gabs Investments Private Limited (Director, since 01 Mar 2017, revenue ₹35.46 Cr (FY 2025)); Rivea Foundation (Director, since 20 Sep 2024, revenue ₹20 Lakh (FY 2025)); Riteaid Enterprises Llp (Designated Partner, since 20 Dec 2017).
Rajesh Mannalal Agrawal was first appointed on 28 Dec 2001 as Director at Ganga Builders Private Limited. The most recent appointment on record is 20 Sep 2024 at Rivea Foundation.
The 3 current companies of Rajesh Mannalal Agrawal that report revenue have a combined latest revenue of ₹4,778 Cr: Ajanta Pharma Limited ₹4,743 Cr (FY 2025); Gabs Investments Private Limited ₹35.46 Cr (FY 2025); Rivea Foundation ₹20 Lakh (FY 2025).
Rajesh Mannalal Agrawal held 38 earlier board appointments: Sbfc Finance Limited (Director, 11 Nov 2020 to 12 Nov 2025); Alpha Alternatives Msar Llp (Partner, 03 Jul 2023 to 02 May 2024); Altacura Ai Absolute Return Fund Llp (Partner, 31 Aug 2023 to 31 Mar 2024); Cdc Pharma Private Limited (Director, 29 Jun 2005 to 29 Apr 2013); Zillion Labs Private Limited (Director, 30 Jun 2006 to 29 Apr 2013); and 33 more.
The current boards of Rajesh Mannalal Agrawal's companies include Arvind Kanhaiyalal Agrawal (Ajanta Pharma Limited), David Paul Rasquinha (Ajanta Pharma Limited), Gaurang Chinubhai Shah (Ajanta Pharma Limited), Madhusudan Bhagwandas Agrawal (Ajanta Pharma Limited), Mannalal Bhagwandas Agrawal (Ajanta Pharma Limited), Medha Vinay Joshi (Ajanta Pharma Limited), among others.